Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-24-043042
Filing Date
2024-10-08
Accepted
2024-10-08 07:16:54
Documents
5
Effectiveness Date
2024-10-08

Document Format Files

Seq Description Document Type Size
1 S-8 POS ef20036391_s8pos.htm S-8 POS 75784
2 EXHIBIT 5.1 ef20036391_ex5-1.htm EX-5.1 10655
3 EXHIBIT 23.1 ef20036391_ex23-1.htm EX-23.1 2470
4 EXHIBIT 23.2 ef20036391_ex23-2.htm EX-23.2 2869
5 image0.jpg GRAPHIC 727516
  Complete submission text file 0001140361-24-043042.txt   1094939
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 POS | Act: 33 | File No.: 333-274228 | Film No.: 241359177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)